configuration crystallography asymmetric center access isomeric enantiomer
diastereoisomer atomic number Priority
magnification solubility spatial sequence in vivo/in vitro receptor
intravenous injection静脉注射 be susceptible to敏感的 With respect to contract Substrate epoxidation
carcinogen oxidation /oxidase preparation predominant species complex
dehydrase/dehydrogenase/decarboxylase/hydrolytic enzymes/isomerase/permease Choline one out of every ten 十分之一 clinical 临床的 interaction excrete/excretion inversion Coordination Delay
Efficacy in place相称的,合适的 entity drug development
attrition toxicity/toxic/ toxicology/ Anti-infectives Healthcare
repro-toxicology/genotoxicity drug candidate
indication pharmacokinetics adverse profile formulary/formulation/formulor onset
dose/once a day dosing dosage/dosage form/overdosage regulatory interdependent subacute亚急性的/chronic clinical/preclinical vital optimum/ optimize impurity pilot plant critical path criteria update in parallel adequate stability
potency dermal cardiovascular 心血管的
respiratory nervous concurrently label
synergies 协同作用 antagonize reversible/irreversible permissible lifespan disease tumour inhaler capsule rodent
foetal teratology exposure patch